tiprankstipranks
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS

Phasebio Pharmaceuticals (PHAS) Similar Stocks

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
AbbVie
256.87B
19.34
30.05%
5 Buy
5 Hold
1 Sell
Moderate Buy
premium
Amgen
143.55B
21.57
31.50%
4 Buy
6 Hold
4 Sell
Hold
premium
Gilead Sciences
100.77B
30.38
27.58%
9 Buy
8 Hold
0 Sell
Moderate Buy
premium
Moderna
60.86B
5.73
-35.26%
7 Buy
5 Hold
0 Sell
Moderate Buy
premium
Vertex Pharmaceuticals
79.27B
24.37
60.65%
9 Buy
7 Hold
0 Sell
Moderate Buy
premium
Phasebio Pharmaceuticals
2.59M
-0.02
0 Buy
3 Hold
0 Sell
Hold
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis